AC Immune and J&J Advance Tau-Targeting Alzheimer’s Vaccine

Encouraging Early Efficacy Signs

 
• By Andrew McConaghie
  
AC Immune
AC Immune has suffered two setbacks to its Alzheimer's pipeline this year, but is moving ahead with its novel vaccination candidate. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Neurological

More from Therapy Areas